Highlights include obstructive sleep apnea as a factor for T2DM; a test that distinguishes between T1DM and T2DM; and missed opportunities in diabetes prevention.
Endocrinology Month in Review: April 2024
Diabetes Dialogue: 2024 ACP Type 2 Diabetes Recommendations
ACP's New Type 2 Diabetes Guidance Recommends SGLT2is, GLP-1 RAs as Second-Line to Metformin
Diabetes Dialogue: STEP HFpEF DM and Fair Allocation of Incretin-Based Therapies
Insulin Glargine Biosimilar Demonstrates Bioequivalence to Originator for Type 2 Diabetes
Poorly Controlled Type 1 Diabetes Associated with MASLD in Children, Adolescents